Halo Collective Inc. (HCANF)
Halo Collective Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $15,081. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -341.8%. Its beta of -1.69 implies it has historically moved less than the broad market.
Founded in 2016 and headquartered in Toronto, Canada, Halo Collective Inc. is a vertically integrated cannabis company. (The firm adopted its current name in January 2021, previously operating as Halo Labs Inc.) Its core operations involve cultivating, manufacturing, and distributing cannabis products throughout the United States. The company specializes in growing, extracting, and processing various forms of cannabis, including flowers, oils, and concentrates. Beyond these, Halo Collective also offers a range of edible products, such as cannabis-infused gummies and a distinctive syrup beverage, available in California and Oregon. Halo Collective markets both its own branded products—like Hush, Mojave, and Exhale—and private label items, primarily selling its cannabis offerings to dispensaries. Its clientele includes licensed retailers and wholesalers. The company also maintains significant collaborations, including a strategic partnership with High Tide Inc. and an alliance with OG DNA Genetics Inc. focused on developing cannabis genetics in Oregon.
Halo Collective Inc. is most often compared with the following Healthcare names: